EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel - Read Press Release

Roundtable: Uncovering Long COVID in drug development

How can clinical trials be designed to best study therapies for treating Long COVID? This panel of experts from Parexel and other industry leaders gives us great insight to the challenges in diagnosis, research and theories of causes for Long COVID.

Watch now

Putting patients at the heart of everything we do

Parexel is in the business of improving the world's health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.

About us

Management Team

Diversity, Equity and Inclusion

Decentralized Clinical Trials (DCTs)

The future is now!

We deliver DCTs with patients at the heart of our approach. Our fully virtual and hybrid DCTs (inclusive of home nursing) demonstrate the Parexel Promise – our commitment to treating patients and caregivers as an essential part of our team of clinical research organization experts.

Learn more

Navigating Long COVID Syndrome

During this time, we continue to be committed to our customers’ business while putting the safety of patients, partners and our employees at the heart of everything we do.

Long COVID Syndrome

COVID-19 Response

COVID-19 Data Clearinghouse

Panel discussion: Key considerations in rare disease drug development

There are thousands of identified rare diseases today, yet only a small percentage of them have treatments readily available. What are the main challenges and opportunities in driving successful rare disease trials? In an informative panel discussion, Parexel experts address the complexities of rare disease drug development.

Learn more & Register

Four ways to increase rare disease drug development success

Only a small percentage of rare diseases have treatments readily available. Get the Parexel Biotech perspective on maximizing the chances of success and addressing some of the most significant challenges in rare disease drug development.

Download eBook

Roundtable: Uncovering Long COVID in drug development

Putting patients at the heart of everything we do

Decentralized Clinical Trials

Navigating Long COVID Syndrome

Panel discussion: Key considerations in rare disease drug development

Four ways to increase rare disease drug development success

Get reliable COVID-19 information in one place

The future of clinical trials is now, and we're committed to creating innovations that make this research accessible to more people. That's why, together with Innoplexus, we've made a single, virtual space for everyone to access reliable COVID-19 information for free.

Visit Our COVID-19 Data Clearinghouse Now

Solutions Highlights

Clinical Development & Clinical Research Services

Putting patients at the center of the clinical research process.

Learn more

Regulatory & Access

Bringing together the industry’s best minds for smarter, faster and sustained patient access.

Learn more

Biotech

Navigating the journey to a life-changing endpoint, together.

Learn more

FSP

We find the expertise you need, matched to the right fit for your company.

Learn more

Parexel Resource Center

Browse the Parexel Resource Center for our latest content on clinical trial supplies and logistics, innovation, drug safety, cell & gene therapy, and more!

Visit Resource Center